Jennifer Chunias, a partner in the firm's Litigation Department, specializes in white collar criminal defense and government and internal investigations, as well as post-closing disputes and litigation. She has defended entities and individuals in a variety of investigations by federal, state and local law enforcement and regulators, including the Department of Justice, the U.S. Securities and Exchange Commission, the Massachusetts Securities Division, and FINRA. She also has litigated civil and criminal cases in state and federal court, and routinely handles escrow and other post-closing indemnification disputes.





Ms. Chunias has extensive experience representing corporations and individuals in connection with civil and criminal government investigations and prosecutions, most notably in relation to alleged violations of the Foreign Corrupt Practices Act and the federal False Claims Act, as well as health care fraud, securities fraud, insider trading, visa fraud, and export violations.

Ms. Chunias also has extensive experience conducting internal investigations for public and private companies, audit committees, and other special board committees, including investigations into whistleblower complaints arising under the Sarbanes-Oxley Act and Dodd-Frank Act. She routinely works with clients on the development and implementation of appropriate policies and remedial actions to address compliance and internal control deficiencies identified through such investigations, and advises technology and life sciences, private equity, and other clients on global corruption risks in IPO and transactional due diligence contexts.

Among her recent matters, Ms. Chunias’s representations include:

  • A global technology company in connection with False Claim Act qui tam litigation and criminal investigations by the U.S. Attorney's Office and the U.S. Department of Justice, National Security Division, relating to defense contracts and allegations of visa fraud, contract fraud, and ITAR violations.
  • Research misconduct investigations and related litigation on behalf of universities and research institutions. Such representations have included the successful dismissal of a federal lawsuit challenging an institutional research misconduct investigation on behalf of Harvard Medical School;
  • The Special Board Committee of a public medical technology company in relation to an internal investigation of whistleblower allegations of FCPA violations and bribery relating to import of company products into Russia and Eastern Europe;
  • A U.S.-based global manufacturer of scientific instruments and medical devices in connection with investigations by the SEC, DOJ and Hong Kong Independent Commission Against Corruption into alleged bribery and corruption violations at several of the Company's China subsidiaries, including relating to the use of third-party intermediaries in connection with contracts with state-owned entities;
  • Various technology and life sciences companies and private equity portfolio companies in post-closing disputes, government inquiries, and internal investigations;
  • A financial consulting firm in False Claim Act and class action litigation arising out of “pay-to-play” allegations relating to the New Mexico State pension system;
  • The former CEO of a pharmaceutical and medical device company in connection with a federal indictment relating to the company's sale of allegedly unapproved and adulterated drugs, successfully arguing for a significant downward departure following the entry of a guilty plea;
  • A private healthcare consulting firm in connection with multiple FCA qui tam whistleblower suits arising out of allegations that the company assisted hospitals seeking and receiving inflated Medicare and Medicaid reimbursements;
  • A national pension consulting firm in connection with claims relating to the Madoff Ponzi scheme; and
  • The former president of a publicly-traded home healthcare company in connection with an investigation by the DOJ, successfully arguing for a significant downward departure following entry of a guilty plea on charges of money laundering and filing false tax returns.
Professional Activities

In 2016, Ms. Chunias was appointed by Massachusetts Governor Charlie Baker to the State Ballot Law Commission.

Ms. Chunias has served on the Board of the Women's Bar Foundation, on the BBA's Individual Rights Responsibilities Section Steering Committee, and as a pro bono Bar Advocate, handling dozens of court appointments in the Criminal Division of the Boston Municipal Court.

Professional Experience

Prior to joining Goodwin in 2005, Ms. Chunias was a lecturer at Harvard Law School. Before that, she was an associate in the Litigation Practice Group at Testa, Hurwitz & Thibeault, LLP in Boston.


Ms. Chunias is listed in Global Investigations Review 100, a guide to the world’s leading firms for corporate investigations. In 2009, Ms. Chunias was selected by the Boston Business Journal as one of the top 40 business leaders in Massachusetts under the age of 40 and honored at a "Women of Justice" event by Massachusetts Lawyers Weekly, the Women's Bar Association and the Massachusetts Association of Women Lawyers. She also was selected as an "Up and Coming Lawyer" for 2005 by Massachusetts Lawyers Weekly and named a Massachusetts Super Lawyer "Rising Star" in 2006, 2007, 2008 and 2009.

In The News


Dans les Nouvelles




Lettres de Créance



Northeastern University School of Law
The University of Vermont





U.S. District Court of Connecticut
U.S. District Court for the District of Massachusetts
Get In Touch
Entrer en contact
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos clients comptent sur nous pour des services de conseil de classe mondiale, des conseils sur le travail transactionnel complexe et des litiges à enjeux élevés. Spécialisés dans les domaines de la finance, des sciences de la vie, du capital-investissement, de l'immobilier et de la technologie, nous utilisons une approche collaborative et interdisciplinaire pour résoudre les problèmes les plus complexes de nos clients. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique